Compare Mutual Funds

Pros
Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
8/8
Category

Equity, Sector - Healthcare

Fund Age

13 Years 10 Months

Fund AUM

₹9479 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1%

Exit Load

1%

Benchmark Index

BSE Healthcare TR INR

No of Holdings

38

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(13.31%)
  2. Lupin Ltd(7.25%)
  3. Divi's Laboratories Ltd(6.52%)
  4. Cipla Ltd(6.03%)
  5. Apollo Hospitals Enterprise Ltd(5.3%)
No of Sectors

1

Top 3 Sectors

Health

(100%)

Equity %

97.32%

Debt %

-

P/E

39.2

P/B

5.82

Credit Quality

-

Modified Duration

-

YTM

-

1-Month Return

-1.4%

3-Month Return

6.1%

6-Month Return

10.78%

1-Year Return

10.7%

3-Year Return

18.57%

5-Year Return

13.65%

Sharpe

0.89

Alpha

-1.21

Beta

0.88

Standard Deviation

14.77

Information Ratio

-0.88

Description

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Sailesh Raj Bhan, Amber Singhania, Kinjal Desai

Most Popular Comparisons